# OnCo record nct04523272 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04523272/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04523272", "NCT04523272" ;
  schema:name "A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer"@en ;
  schema:description "A phase 3 trial testing TQB2450 in renal cell carcinoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04523272/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04523272> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-08-25" ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:drugs <https://onco.cc/drugs/tqb2450/> ;
  onco:companies <https://onco.cc/companies/sino-biopharm/> .